selinexor,imatinib
karyopharm therapeutics,novartis
['#gi', 'selinexor', 'geis,41', 'seligist', 'imatinib']
data from the seligist/geis-41 trial presented by at #esmo22 show promising antitumor activity of selinexor plus imatinib in pts with advanced #gist 
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. 
@iCERCA centre